PAROXETINE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paroxetine Mesylate, and what generic alternatives are available?
Paroxetine Mesylate is a drug marketed by Actavis Labs Fl Inc and Prinston Inc and is included in two NDAs.
The generic ingredient in PAROXETINE MESYLATE is paroxetine mesylate. There are thirty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the paroxetine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paroxetine Mesylate
A generic version of PAROXETINE MESYLATE was approved as paroxetine mesylate by ACTAVIS LABS FL INC on June 20th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PAROXETINE MESYLATE?
- What are the global sales for PAROXETINE MESYLATE?
- What is Average Wholesale Price for PAROXETINE MESYLATE?
Summary for PAROXETINE MESYLATE
Recent Clinical Trials for PAROXETINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Alphacait, LLC | Phase 2 |
| Noven Therapeutics | Phase 1 |
Pharmacology for PAROXETINE MESYLATE
| Drug Class | Serotonin Reuptake Inhibitor |
| Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PAROXETINE MESYLATE
Paragraph IV (Patent) Challenges for PAROXETINE MESYLATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| BRISDELLE | Capsules | paroxetine mesylate | 7.5 mg | 204516 | 1 | 2014-04-07 |
US Patents and Regulatory Information for PAROXETINE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | PAROXETINE MESYLATE | paroxetine mesylate | CAPSULE;ORAL | 207139-001 | Jun 20, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Prinston Inc | PAROXETINE MESYLATE | paroxetine mesylate | CAPSULE;ORAL | 207188-001 | Aug 18, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
